Lutetium-177-PSMA-617 for Prostate Cancer

N Engl J Med. 2021 Dec 23;385(26):2495. doi: 10.1056/NEJMc2116647.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • Humans
  • Lutetium*
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms*
  • Radioisotopes

Substances

  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • PSMA-617
  • Radioisotopes
  • Lutetium
  • Lutetium-177
  • Prostate-Specific Antigen